By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tissue-based cancer diagnostics shop BioMarker Strategies has raised $1.1 million of a targeted $4 million round, a company executive confirmed.

In an e-mail to GenomeWeb Daily News, BioMarker Strategies President Scott Allocco said that funds from the round will be used to support the first clinical use of its flagship platform, called SnapPath, in patients with advanced melanoma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.